Showing results (71-80 of 220) with videos related to
Sort By:
Pageof 22
European Journal of Gastroenterology & Hepatology|August 25, 2000
Smoking and inflammatory bowel diseaseD T Rubin, S B HanauerAlimentary Pharmacology & Therapeutics|December 21, 2002
Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitisW J Sandborn, S B HanauerJournal of Clinical Microbiology|December 1, 1993
Reliability of the E test for detection of ampicillin, vancomycin, and high-level aminoglycoside resistance in Enterococcus sppJ E Schulz, D F SahmCurrent Gastroenterology Reports|September 12, 2000
Mesalamine for prophylaxis of small bowel Crohn's disease recurrenceW M Bauer, A Brzezinski, B A LashnerDigestive Diseases and Sciences|November 26, 1999
Can colectomy cure immune thrombocytopenic purpura in a patient with ulcerative colitis?W M Bauer, A Litchtin, B A LashnerJPEN. Journal of Parenteral and Enteral Nutrition|September 1, 1994
Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resectionS A Schuette, B A Lashner, M JanghorbaniJournal of Clinical Gastroenterology|August 1, 1990
Randomized clinical trial of two colonoscopy preparation methods for elderly patientsB A Lashner, C S Winans, M O BlackstoneJournal of Clinical Microbiology|March 1, 1996
Factors influencing the vitek gram-positive susceptibility system's detection of vanB-encoded vancomycin resistance among enterococciB Jett, L Free, D F SahmGene|February 14, 1993
The vanB gene of vancomycin-resistant Enterococcus faecalis V583 is structurally related to genes encoding D-Ala:D-Ala ligases and glycopeptide-resistance proteins VanA and VanCS Evers, D F Sahm, P CourvalinAlimentary Pharmacology & Therapeutics|October 18, 2005
The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitisJ M Wolf, L A Rybicki, B A LashnerPageof 22